Raj Capsules Private Limited

Raj Capsules Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U24231DL1997PTC086136 Incorporated 26 March 1997 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹7.9 Cr
▲ 20% YoY
Net profit · FY 2025
₹27.4 Lakh
Net margin 3.5%
EBITDA · FY 2025
₹35.87 Lakh
EBITDA margin 4.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹4.45 Lakh
Issued & subscribed
Company age
29 yrs
Est. 1997
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Raj Capsules Private Limited

Data last updated:

Raj Capsules Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 March 1997 and has been in existence for over 29 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1997PTC086136. Its GSTIN is 07AAACR5259D1ZI (Delhi).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.45 Lakh. It is led by directors including Karan Sawhney and Priya Sawhney.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1678/5&6 Khajoor Building Bhagirath Palace, Delhi, India – 110006.

As per the financials filed for FY 2025, the company reported a revenue of ₹7.9 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹27.4 Lakh (net margin 3.5%) and EBITDA of ₹35.87 Lakh (EBITDA margin 4.5%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 8% over five years.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rajcaps.in.

Company details

CIN U24231DL1997PTC086136
Registration Number 086136
Incorporation Date 26 March 1997
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Raj Capsules Private Limited's registered office is in Delhi, Delhi. Its website is rajcaps.in. Its e-mail address is in the company report.

  • Email
  • Website
  • Registered Address
    1678/5&6 Khajoor Building Bhagirath Palace, Delhi, India – 110006
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Raj Capsules Private Limited, buy the company report.

Comprehensive company report
Raj Capsules Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Raj Capsules is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Raj Capsules Private Limited, buy the company report.

Financials of Raj Capsules Private Limited

FY 2025 filings available

Raj Capsules Private Limited reported revenue of ₹7.9 Cr (up 20% YoY) for FY 2025.

Revenue · FY 2025
₹7.9 Cr ▲ 20%
Net profit · FY 2025
₹27.4 Lakh margin 3.5%
EBITDA · FY 2025
₹35.87 Lakh margin 4.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▼ 6%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▲ 176%
3 years · compounded
▼ 30%
5 years · compounded
▼ 16%

Revenue rose 20% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 8%. EBITDA rose 176% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹35.87 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹27.4 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.5%
Net Profit Margin3.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Raj Capsules Private Limited, buy the company report.

Board of directors of Raj Capsules Private Limited

Raj Capsules has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Karan SawhneyDirector26 Mar 199729 Years 6 MonthsCurrent
Priya SawhneyDirector16 Feb 200422 Years 8 MonthsCurrent
Kumud KapoorDirector26 Mar 199729 Years 6 MonthsCurrent

Peer comparison

Raj Capsules Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Orient Drugs Private Limited₹7.95 Cr (FY 2025)-2.0%Malappuram, Kerala, India
Ndcare Nirogam Private Limited₹7.95 Cr (FY 2025)2.0%Amritsar, Punjab, India
Spasibo Enterprise Private Limited₹7.9 Cr (FY 2025)-47.0%Bishnupur, West Bengal, India
Raj Capsules Private Limitedthis company₹7.9 Cr (FY 2025)₹27.4 Lakh3.5%20.0%Delhi, India
Nephcore India Private Limited₹7.89 Cr (FY 2024)38.0%Delhi, India
Eva Biotech Private Limited₹7.89 Cr (FY 2024)111.0%Jaipur, Rajasthan, India
Mahak Pharma Private Limited₹7.89 Cr (FY 2024)322.0%New Delhi, Delhi, India

To see the full peer comparison of Raj Capsules Private Limited, buy the company report.

Auditor

Raj Capsules Private Limited is audited by MITTAL GARG GUPTA AND CO. for the financial year 2022.

Auditor firmFinancial yearFirm registration number
MITTAL GARG GUPTA AND CO.FY 2022016591N

Shareholding

The shareholding of Raj Capsules Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Raj Capsules Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Raj Capsules Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Raj Capsules has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAACR5259D1ZIDelhiActive01 Jul 2017

To see the full GST registrations and return filing status of Raj Capsules Private Limited, buy the company report.

Recent activity

Raj Capsules Private Limited has 3 board changes on record since 1997: 3 appointments. The latest: Priya Sawhney was appointed as Director on 16 Feb 2004.

AGM
Raj Capsules Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Raj Capsules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Priya Sawhney was appointed as Director.
Appointed
Karan Sawhney was appointed as Director.
Appointed
Kumud Kapoor was appointed as Director.
Incorporation
26 Mar 1997
Raj Capsules Private Limited was registered on 26 Mar 1997 with Roc Delhi & aged 29 years 6 months as per MCA records.

Frequently asked questions

Raj Capsules is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 March 1997 (29+ years old) and is registered under CIN U24231DL1997PTC086136.

Raj Capsules has 3 current directors:

The latest financial statements of Raj Capsules on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Raj Capsules is 07AAACR5259D1ZI, registered in Delhi.

The CIN (Corporate Identification Number) of Raj Capsules is U24231DL1997PTC086136. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Raj Capsules was incorporated on 26 March 1997, making it 29+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Raj Capsules by revenue are Orient Drugs Private Limited, Ndcare Nirogam Private Limited, Spasibo Enterprise Private Limited, Nephcore India Private Limited, Eva Biotech Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Priya Sawhney was appointed as Director on 16 Feb 2004. Karan Sawhney was appointed as Director on 26 Mar 1997. Kumud Kapoor was appointed as Director on 26 Mar 1997.

Raj Capsules can be reached through the website rajcaps.in. Its registered office is in Delhi, India.

The registered office of Raj Capsules is at 16785&6 Khajoor Building Bhagirath Palace, Delhi, India – 110006.

Raj Capsules operates in the pharma industry, in the pharmaceutical retailers and distributors segment.